Showing 1,021 - 1,040 results of 59,642 for search '(( 5 point decrease ) OR ( 5 ((((we decrease) OR (mean decrease))) OR (nn decrease)) ))', query time: 1.21s Refine Results
  1. 1021
  2. 1022
  3. 1023

    sC5b-9 patients decrease in patients treated with mycophenolate mofetil. by Joshua M. Thurman (517193)

    Published 2015
    “…<p>The levels of (A) Ba and (B) Bb did not change over the course of the study (n = 19 for all time-points). (C) The levels of sC5b-9 decreased over time (P < 0.001 by linear regression; n = 19 for all time-points). …”
  4. 1024
  5. 1025

    Image 5_Exploration of the diagnostic and prognostic roles of decreased autoantibodies in lung cancer.tif by Ying Ye (72583)

    Published 2025
    “…Moreover, 5 of the decreased autoantibodies can also be applied for supervising bone metastasis in lung adenocarcinoma. …”
  6. 1026
  7. 1027
  8. 1028
  9. 1029
  10. 1030
  11. 1031
  12. 1032

    Effects of α-syn expression on 20/26S proteasomal activity in living SH-SY5Y cells. by Lisa Zondler (3405464)

    Published 2017
    “…(A) Immunocytochemistry confirms comparable levels of α-syn expression in wild-type- and A53T α-syn expressing SH-SY5Y cells indicated by red fluorescence. (B) Both expression of wild-type and A53T α-syn results in decreased proteasomal activity as indicated by decreased relative fluorescence intensity (RFU) in this setting. …”
  13. 1033
  14. 1034
  15. 1035

    Effects of conivaptan on brain water content (BWC), blood-brain-barrier (BBB) disruption, plasma and urine sodium and osmolality. by Emil Zeynalov (596088)

    Published 2015
    “…Following MCAO, Evans Blue (EB) extravasation index (I/C) was increased in vehicle treated mice, and reduced in conivaptan treated mice, naïve, n = 5, vehicle, n = 8, Conivaptan 0.2 mg, n = 8. (C, D) Conivaptan treatment of 0.2 mg resulted in an elevation of plasma sodium and osmolality, and decreased urine sodium and osmolality due to aquaresis. …”
  16. 1036

    S1 File - by Yonghui Zhang (279832)

    Published 2024
    Subjects:
  17. 1037
  18. 1038
  19. 1039
  20. 1040